A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

Multiple candidate vaccines to prevent COVID-19 have entered large-scale phase 3 placebo-controlled randomized clinical trials, and several have demonstrated substantial short-term efficacy. At some point after demonstration of substantial efficacy, placebo recipients should be offered the efficacio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intern Med
Main Authors: Follmann, Dean, Fintzi, Jonathan, Fay, Michael P., Janes, Holly E., Baden, Lindsey R., El Sahly, Hana M., Fleming, Thomas R., Mehrotra, Devan V., Carpp, Lindsay N., Juraska, Michal, Benkeser, David, Donnell, Deborah, Fong, Youyi, Han, Shu, Hirsch, Ian, Huang, Ying, Huang, Yunda, Hyrien, Ollivier, Luedtke, Alex, Carone, Marco, Nason, Martha, Vandebosch, An, Zhou, Honghong, Cho, Iksung, Gabriel, Erin, Kublin, James G., Cohen, Myron S., Corey, Lawrence, Gilbert, Peter B., Neuzil, Kathleen M.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Physicians 2021
Assuntos:
Research and Reporting Methods
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099035/
https://ncbi.nlm.nih.gov/pubmed/33844575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-8149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados